Janssen, Gilead Clear Mylan To Sell Generic HIV Drug
Janssen Pharmaceutica NV on Thursday told a Delaware federal court that it has granted Mylan Pharmaceuticals Inc. a license to use eight patents tied to the HIV treatment Complera, ending an...To view the full article, register now.
Already a subscriber? Click here to view full article